Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nasopharynx administration of mupirocin for prophylactic treatment of recurrent otitis media

Nasopharynx administration of mupirocin for prophylactic treatment of recurrent otitis media

US Patent 6001870 · Granted Dec 14, 1999

Estimated economic value: $13,134,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Solid forms and combination compositions comprising a beta-lactamase inhibitor a2025
Solid forms and combination compositions comprising a beta-lactamase inhibitor a2023
Solid forms and combination compositions comprising a beta-lactamase inhibitor a2021
Stable pharmaceutical compositions of dalbavancin and methods of administration2006
Methods of administering dalbavancin for treatment of bacterial infections2005
Calcium mupirocin sprayable formulation2002